XTL Biopharmaceuticals Market Cap

XTL Biopharmaceuticals has a market cap or net worth of 75.26 million as of December 20, 2024. Its market cap has increased by 294.62% in one year.

Market Cap

75.26M

Enterprise Value

66.63M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

6.10

Market Cap Chart

Since August 30, 2005, XTL Biopharmaceuticals's market cap has decreased from 805.44M to 75.26M, a decrease of -90.66%. That is a compound annual growth rate of -11.55%.

Market Cap History

Date	Market Cap	% Change
Dec 19, 2024	63.97M	235.43%
Dec 31, 2023	19.07M	-14.63%
Dec 29, 2022	22.34M	-52.02%
Dec 30, 2021	46.56M	-7.60%
Dec 31, 2020	50.39M	108.51%
Dec 31, 2019	24.17M	-26.56%
Dec 31, 2018	Pro	Pro
Dec 31, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro
Dec 31, 2014	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition